GlassScriptPhysician profile
Hugo Robert Paulson
NPI 1871917260
$478.51
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Dermatopathology (Dermatology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $239.20 | 2019 | |
| Pfizer INC. | $52.89 | 2019 | |
| Janssen Biotech, INC. | $40.34 | 2019 | |
| Amgen INC. | $34.92 | 2019 | |
| Sun Pharmaceutical Industries INC. | $22.46 | 2019 | |
| Almirall LLC | $19.74 | 2019 | |
| Celgene Corporation | $19.35 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.70 | 2019 | |
| Lilly USA, LLC | $17.11 | 2019 | |
| Mayne Pharma Commercial LLC | $13.80 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hugo Paulson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.